Lactate promotes glutamine uptake and metabolism in oxidative cancer cells.

Perez Escuredo, Jhudit;Dadhich, Rajesh Kumar;Dhup, Suveera;Cacace, Andrea;Sonveaux, Pierre;et.al.
(2016) Cell Cycle — Vol. 15, n° 1, p. 72-83 (2016)

Files

36Escuredo8002_1_merged_1444830044.pdf
  • Closed Access
  • Adobe PDF
  • 1.69 MB

Details

Authors
  • Perez Escuredo, JhuditUCLouvain
    Author
  • Dadhich, Rajesh KumarUCLouvain
    Author
  • Dhup, SuveeraUCLouvain
    Author
  • Cacace, AndreaUCLouvain
    Author
  • Van Hee, Vincent FUCLouvain
    Author
  • De Saedeleer, ChristopheUCLouvain
    Author
  • Sboarina, MartinaUCLouvain
    Author
  • Rodriguez, FabienUCLouvain
    Author
  • Fontenille, Marie-JoséphineUCLouvain
    Author
  • Brisson, LucieUCLouvain
    Author
  • Porporato, PaoloUCLouvain
    Author
  • Author
Show more
Abstract
Oxygenated cancer cells have a high metabolic plasticity as they can use glucose, glutamine and lactate as main substrates to support their bioenergetic and biosynthetic activities. Metabolic optimization requires integration. While glycolysis and glutaminolysis can cooperate to support cellular proliferation, oxidative lactate metabolism opposes glycolysis in oxidative cancer cells engaged in a symbiotic relation with their hypoxic/glycolytic neighbors. However, little is known concerning the relationship between oxidative lactate metabolism and glutamine metabolism. Using SiHa and HeLa human cancer cells, this study reports that intracellular lactate signaling promotes glutamine uptake and metabolism in oxidative cancer cells. It depends on the uptake of extracellular lactate by monocarboxylate transporter 1 (MCT1). Lactate first stabilizes hypoxia-inducible factor-2α (HIF-2α), and HIF-2α then transactivates c-Myc in a pathway that mimics a response to hypoxia. Consequently, lactate-induced c-Myc activation triggers the expression of glutamine transporter ASCT2 and of glutaminase 1 (GLS1), resulting in improved glutamine uptake and catabolism. Elucidation of this metabolic dependence could be of therapeutic interest. First, inhibitors of lactate uptake targeting MCT1 are currently entering clinical trials. They have the potential to indirectly repress glutaminolysis. Second, in oxidative cancer cells, resistance to glutaminolysis inhibition could arise from compensation by oxidative lactate metabolism and increased lactate signaling.
Affiliations

Citations

Perez Escuredo, J., Dadhich, R. K., Dhup, S., Cacace, A., Van Hee, V. F., De Saedeleer, C., Sboarina, M., Rodriguez, F., Fontenille, M.-J., Brisson, L., Porporato, P., & Sonveaux, P. (2016). Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. Cell Cycle, 15(1), 72-83. https://doi.org/10.1080/15384101.2015.1120930 (Original work published 2016)